Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography

J. Klein, D. Fernandes, M. Gazarian, G. Kent, G. Koren

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

An HPLC assay is described for the measurement of prilocaine and lidocaine (components of the local anesthetic cream EMLA) as well as the prilocaine metabolite, o-toluidine, in plasma. The method uses UV detection, is simple, sensitive and most important, only a single 200-μl plasma sample is needed for simultaneous analysis of prilocaine, lidocaine and o-toluidine with a detection limit of 4 ng/ml. The plasma, together with the internal standard (bupivacaine) is extracted with diethyl ether under alkaline conditions, followed by the extraction of the analytes from the organic phase into dilute sulphuric acid. An aliquot of the acid extract is injected onto the HPLC system and the effluent is monitored by a UV detector.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume655
Issue number1
DOIs
Publication statusPublished - 22-04-1994

Fingerprint

2-toluidine
Prilocaine
High performance liquid chromatography
Metabolites
Lidocaine
Plasmas
Ultraviolet detectors
Acids
Bupivacaine
Local Anesthetics
Ether
Effluents
Assays

All Science Journal Classification (ASJC) codes

  • Chemistry(all)

Cite this

@article{1eb1f6e5439a416e8b191852a22dbdd9,
title = "Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography",
abstract = "An HPLC assay is described for the measurement of prilocaine and lidocaine (components of the local anesthetic cream EMLA) as well as the prilocaine metabolite, o-toluidine, in plasma. The method uses UV detection, is simple, sensitive and most important, only a single 200-μl plasma sample is needed for simultaneous analysis of prilocaine, lidocaine and o-toluidine with a detection limit of 4 ng/ml. The plasma, together with the internal standard (bupivacaine) is extracted with diethyl ether under alkaline conditions, followed by the extraction of the analytes from the organic phase into dilute sulphuric acid. An aliquot of the acid extract is injected onto the HPLC system and the effluent is monitored by a UV detector.",
author = "J. Klein and D. Fernandes and M. Gazarian and G. Kent and G. Koren",
year = "1994",
month = "4",
day = "22",
doi = "10.1016/0378-4347(94)00062-X",
language = "English",
volume = "655",
pages = "83--88",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "1387-2273",
publisher = "Elsevier BV",
number = "1",

}

Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography. / Klein, J.; Fernandes, D.; Gazarian, M.; Kent, G.; Koren, G.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 655, No. 1, 22.04.1994, p. 83-88.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography

AU - Klein, J.

AU - Fernandes, D.

AU - Gazarian, M.

AU - Kent, G.

AU - Koren, G.

PY - 1994/4/22

Y1 - 1994/4/22

N2 - An HPLC assay is described for the measurement of prilocaine and lidocaine (components of the local anesthetic cream EMLA) as well as the prilocaine metabolite, o-toluidine, in plasma. The method uses UV detection, is simple, sensitive and most important, only a single 200-μl plasma sample is needed for simultaneous analysis of prilocaine, lidocaine and o-toluidine with a detection limit of 4 ng/ml. The plasma, together with the internal standard (bupivacaine) is extracted with diethyl ether under alkaline conditions, followed by the extraction of the analytes from the organic phase into dilute sulphuric acid. An aliquot of the acid extract is injected onto the HPLC system and the effluent is monitored by a UV detector.

AB - An HPLC assay is described for the measurement of prilocaine and lidocaine (components of the local anesthetic cream EMLA) as well as the prilocaine metabolite, o-toluidine, in plasma. The method uses UV detection, is simple, sensitive and most important, only a single 200-μl plasma sample is needed for simultaneous analysis of prilocaine, lidocaine and o-toluidine with a detection limit of 4 ng/ml. The plasma, together with the internal standard (bupivacaine) is extracted with diethyl ether under alkaline conditions, followed by the extraction of the analytes from the organic phase into dilute sulphuric acid. An aliquot of the acid extract is injected onto the HPLC system and the effluent is monitored by a UV detector.

UR - http://www.scopus.com/inward/record.url?scp=0028274125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028274125&partnerID=8YFLogxK

U2 - 10.1016/0378-4347(94)00062-X

DO - 10.1016/0378-4347(94)00062-X

M3 - Article

VL - 655

SP - 83

EP - 88

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 1387-2273

IS - 1

ER -